Michel is the Chief Executive Officer of Metronom Health Inc. , an early stage medical device company developing a continuous glucose monitoring system.
Prior to that, he worked for Volcano Corporation where he served in a number of positions from 2002-2013, from Vice President, Europe Africa and Middle-East to Group President, Advanced Imaging Systems, Global Clinical & Scientific Affairs and General Management of Europe, Africa and the Middle-East. Philips acquired Volcano Corporation in 2014.
Michel is also extensively engaged in the medical technology start-up landscape. Michel is a Managing Director of Fjord Ventures LLC, a Southern California based Medical Technology accelerator. Michel is also Chairman of the board and co-founder of Celyad, a NASDAQ and Euronext listed bio-technology company based in Mont-Saint-Guibert, Belgium and Cambridge, Massachusetts. Michel has also founded and led Medpole since 2002, a consulting firm helping early stage European and North-American companies in their development.
Michel obtained a Bachelor of Science degree in Electrical Engineering, and a Masters degree in Biomedical Engineering at the University of Montreal. He also holds an MBA from INSEAD, France.